BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
BioInvent International Market Cap: 309.28M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 309.28M |
| November 12, 2024 | 309.28M |
| November 11, 2024 | 309.28M |
| November 08, 2024 | 309.28M |
| November 07, 2024 | 309.28M |
| November 06, 2024 | 309.28M |
| November 05, 2024 | 309.28M |
| November 04, 2024 | 309.28M |
| November 01, 2024 | 309.28M |
| October 31, 2024 | 309.28M |
| October 30, 2024 | 309.28M |
| October 29, 2024 | 309.28M |
| October 28, 2024 | 309.28M |
| October 25, 2024 | 309.28M |
| October 24, 2024 | 309.28M |
| October 23, 2024 | 309.28M |
| October 22, 2024 | 309.28M |
| October 21, 2024 | 309.28M |
| October 18, 2024 | 309.28M |
| October 17, 2024 | 309.28M |
| October 16, 2024 | 309.28M |
| October 15, 2024 | 309.28M |
| October 14, 2024 | 309.28M |
| October 11, 2024 | 309.28M |
| October 10, 2024 | 309.28M |
| Date | Value |
|---|---|
| October 09, 2024 | 309.28M |
| October 08, 2024 | 309.28M |
| October 07, 2024 | 309.28M |
| October 04, 2024 | 309.28M |
| October 03, 2024 | 309.28M |
| October 02, 2024 | 309.28M |
| October 01, 2024 | 309.28M |
| September 30, 2024 | 309.28M |
| September 27, 2024 | 309.28M |
| September 26, 2024 | 309.28M |
| September 25, 2024 | 309.28M |
| September 24, 2024 | 309.28M |
| September 23, 2024 | 309.28M |
| September 20, 2024 | 309.28M |
| September 19, 2024 | 309.28M |
| September 18, 2024 | 309.28M |
| September 17, 2024 | 309.28M |
| September 16, 2024 | 309.28M |
| September 13, 2024 | 309.28M |
| September 12, 2024 | 309.28M |
| September 11, 2024 | 309.28M |
| September 10, 2024 | 309.28M |
| September 09, 2024 | 309.28M |
| September 06, 2024 | 309.28M |
| September 05, 2024 | 309.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.50M
Minimum
Dec 23 2019
419.40M
Maximum
Jun 01 2021
284.52M
Average
309.28M
Median
Jun 26 2024
Market Cap Benchmarks
| Abliva AB | 16.12M |
| Oncopeptides AB | 23.97M |
| Hansa Biopharma AB | 239.48M |
| BioArctic AB | 1.574B |
| Camurus AB | 3.340B |
Market Cap Related Metrics
| PS Ratio | 84.18 |
| PEG Ratio | -0.2489 |
| Price to Book Value | 3.109 |
| Price | 4.70 |
| Earnings Yield | -12.57% |
| PEGY Ratio | -0.2489 |